Summary

＜P＞The global disposable endoscopes market is projected to reach USD 2.67 billion by 2030, growing from USD 0.95 billion in 2025, at a CAGR of 22.9% from 2025 to 2030.

https://mnmimg.marketsandmarkets.com/Images/disposable-endoscopes-market-overview.webp

The disposable endoscopes market is experiencing strong growth driven by the rising prevalence of chronic diseases, increasing demand for minimally invasive procedures, and ongoing advancements in imaging and optical technologies. Emerging markets offer substantial opportunities due to improving healthcare infrastructure, expanding procedure volumes, and the growth of medical tourism, which facilitate the wider adoption of advanced endoscopic solutions. However, market growth faces challenges such as infection risks, insufficient sterilization and reprocessing practices, and high procedural costs, which may limit broader adoption?particularly in cost-sensitive and resource-limited healthcare settings.
The bronchoscopes segment accounted for the second-largest growth in the disposable endoscopes market in 2024.
By type, the disposable endoscopes market is divided into urology endoscopes, bronchoscopes, cystoscopes, laryngoscopes, GI endoscopes, arthroscopes, and other disposable endoscopes. Among these, the bronchoscopes segment held the second-largest market share in 2024, driven by the increasing global incidence of respiratory diseases, especially lung cancer. According to the American Cancer Society, in 2025, the US is expected to see about 226,650 new lung cancer cases and 124,730 related deaths, while the World Cancer Research Fund reported 2,480,675 new cases worldwide in 2022. This rising disease burden has significantly boosted the demand for bronchoscopy procedures for early diagnosis and treatment. Disposable bronchoscopes are increasingly chosen because they help prevent cross-contamination, eliminate the need for reprocessing, and ensure consistent performance in emergency and intensive care situations. Additionally, advancements in imaging technology and maneuverability, along with growing adoption by hospitals and outpatient clinics, are further driving the growth of this segment, making bronchoscopes the second largest contributor to the disposable endoscopes market.
The surgical segment accounted for the largest share of the disposable endoscopes market in 2024.
By clinical practice, the disposable endoscopes market is divided into diagnostic and surgical uses. In 2024, the surgical use segment held the largest market share. This growth is driven by the rising adoption of minimally invasive surgical procedures across various specialties, including gastroenterology, urology, pulmonology, and gynecology. Surgeons favor disposable endoscopes for their superior sterility, reliable performance, and ability to eliminate risks associated with cross-contamination and reprocessing errors. The increasing prevalence of chronic conditions such as cancer, kidney disorders, and respiratory diseases has led to a rise in surgical procedures that require precise visualization and dependable instrumentation. Additionally, the availability of advanced single-use endoscopes with high-definition imaging and ergonomic designs improves procedural efficiency and safety. Hospitals and outpatient surgical centers are increasingly shifting toward single-use devices to enhance infection control and streamline operations. Collectively, these factors establish the surgical usage segment as the leading contributor to the disposable endoscopes market by clinical application.
Europe accounted for the second-largest position in the disposable endoscopes market during the forecast period.
The global disposable endoscopes market is divided into five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, Europe held the second-largest share in this market. This is due to a mix of demographic trends, high disease rates, and advanced healthcare systems. The region is experiencing notable population aging, with Germany’s population aged 65 and older projected to increase by 41% to 24 million by 2050. Additionally, 19% of the UK population was already over 65 in 2022, leading to higher demand for diagnostic and minimally invasive procedures. The growing burden of chronic diseases and cancer also drives the need for disposable endoscopes, with 53.7% of adults in Germany reporting chronic conditions in 2024, and cancer-related deaths reaching 138,579 in England (2022) and 230,292 in Germany (2023). Coupled with well-established hospitals, the adoption of advanced medical technology, and supportive regulatory frameworks, these factors together create a strong market environment, making Europe a key growth region in the global disposable endoscopes market.
A breakdown of the primary participants referred to for this report is provided below:
? By Company Type: Tier 1 ?40%, Tier 2 ?30%, and Tier 3 ?30%
? By Designation: C-level ?50%, Director level ?30%, and Others ?20%
? By Region: North America ?30%, Europe ? 25%, Asia Pacific ?20%, Latin America ?15%, and Middle East & Africa ?10%
Notes:
Companies are classified into tiers based on their total revenue. The tiers are as follows: Tier 1 = > USD 10.0 billion, tier 2 = USD 1.0 billion to USD 10.0 billion, and tier 3 = < USD 1.0 billion
C-level primaries include CEOs, CFOs, COOs, and VPs.
Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The players operating in the disposable endoscopes market include Olympus Corporation (Japan), Boston Scientific Corporation (US), HOYA Corporation (Japan), Ambu A/s (Denmark), Karl Storz SE & Co. KG (Germany), Hunan Vathin Medical Instrument Co., Ltd. (China), Zhuhai Pusen Medical Technology Co., Ltd. (China), GI View Ltd (Isareal), Richard Wolf GmbH (Germany), Daichuan medica (China), Scivita Medical (China), Uroviu Corporation (US), Neoscope Inc. (US), Verathon Inc. A Ropper Technologies Company (US), Integrated Endoscopy (US), HUGER Medical Instrument Co., Ltd. (China), Guangzhou Red Pine Medical Instrument Co. Ltd. (China), Nanchang WOEK Medical Technology Co., Ltd (China), Innovex Medical Co., Ltd. (China), Xenocor (US), MacroLux Medical Technology Co., Ltd. (China), THE COOPER COMPANIES, INC. (US), Shenzhen HugeMed Medical Technical Development Co., Ltd. (China), and Xi'an Haiye Medical Equipment Co., Ltd. (China).
Research Coverage
This report examines the disposable endoscopes market based on type, application, clinical use, end user, and region. It also explores factors such as drivers, restraints, opportunities, and challenges influencing market growth, and provides an overview of the competitive landscape for market leaders. Additionally, the report analyzes micro markets concerning their individual growth trends and forecasts the revenue of market segments across five major regions and their respective countries.
Reasons to Buy the Report
The report will help both established and smaller firms understand the market, which, in turn, will assist them in increasing their market share. Firms purchasing the report can use one or a combination of the strategies mentioned below to strengthen their position in the market presence.
This report provides insights into the following pointers:
? Analysis of key drivers (Increasing investments, funds, and grants by government and other organizations, growing focus of hospitals to expand endoscopic units, increasing preference for minimally invasive surgeries, rising need for endoscopy to diagnose & treat target diseases), restraints (High overhead costs of endoscopy procedures), opportunities (Rapidly developing healthcare sector in emerging countries), challenges (Environmental concerns related to medical waste disposal, limited reimbursement policies)
? Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the disposable endoscopes market
? Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the disposable endoscopes market
? Market Development: Complete knowledge about profitable developing regions
? Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the disposable endoscopes industry help to diversify the market
? Competitive Assessment: In-depth assessment of market share, growth strategies and product offerings of leading players like Olympus Corporation (Japan), Boston Scientific Corporation (US), HOYA Corporation (Japan), Ambu A/s (Denmark), Karl Storz SE & Co. KG (Germany), Hunan Vathin Medical Instrument Co., Ltd. (China), Zhuhai Pusen Medical Technology Co., Ltd. (China), and among others.

ページTOPに戻る

Table of Contents

＜P＞1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 STUDY SCOPE 26
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 26
1.3.2 INCLUSIONS & EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 27
1.3.4 CURRENCY CONSIDERED 27
1.4 STAKEHOLDERS 28
2 EXECUTIVE SUMMARY 29
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 29
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 30
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 31
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 32
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 33
3 PREMIUM INSIGHTS 34
3.1 DISPOSABLE ENDOSCOPES MARKET OVERVIEW 34
3.2 NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY END USER 35
3.3 GEOGRAPHIC SNAPSHOT OF DISPOSABLE ENDOSCOPES MARKET (2024) 36
3.4 GEOGRAPHIC MIX: DISPOSABLE ENDOSCOPES MARKET, 2025?2030 (USD MILLION) 36
3.5 DISPOSABLE ENDOSCOPES MARKET: DEVELOPING VS. DEVELOPED MARKETS 37
4 MARKET OVERVIEW 38
4.1 INTRODUCTION 38
4.2 MARKET DYNAMICS 38
4.2.1 DRIVERS 38
4.2.1.1 Growing demand for infection control and regulatory push 38
4.2.1.2 Rising burden of chronic diseases 39
4.2.2 RESTRAINTS 39
4.2.2.1 Environmental impact and sustainability concerns 39
4.2.3 OPPORTUNITIES 40
4.2.3.1 Rapidly developing healthcare sector in emerging economies 40
4.2.4 CHALLENGES 40
4.2.4.1 High upfront expenditure per procedure 40
4.3 UNMET NEEDS & WHITE SPACES 41
4.3.1 UNMET NEEDS IN DISPOSABLE ENDOSCOPES MARKET 41
4.3.2 WHITE SPACE OPPORTUNITIES 41
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNTIES 42
4.4.1 INTERCONNECTED MARKETS 42
4.4.2 CROSS-SECTOR OPPORTUNTIES 42
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 42
5 INDUSTRY TRENDS 43
5.1 PORTER’S FIVE FORCES ANALYSIS 43
5.1.1 THREAT OF NEW ENTRANTS 44
5.1.2 THREAT OF SUBSTITUTES 44
5.1.3 BARGAINING POWER OF BUYERS 45
5.1.4 BARGAINING POWER OF SUPPLIERS 45
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 45
5.2 MACROECONOMIC OUTLOOK 45
5.2.1 INTRODUCTION 45
5.2.2 GDP TRENDS AND FORECAST 45
5.2.3 TRENDS IN GLOBAL ENDOSCOPY EQUIPMENT IDUSTRY 47
5.2.4 TRENDS IN GLOBAL FLEXIBLE ENDOSCOPES INDUSTRY 47
5.3 SUPPLY CHAIN ANALYSIS 47
5.4 VALUE CHAIN ANALYSIS 49
5.5 ECOSYSTEM ANALYSIS 50
5.6 PRICING ANALYSIS 51
5.6.1 AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY KEY PLAYER (2022?2024) 51
5.6.2 AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY TYPE (2022?2024) 52
5.6.3 AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY REGION (2022?2024) 53
5.7 TRADE ANALYSIS 53
5.7.1 IMPORT SCENARIO (HS CODE 9018) 53
5.7.2 EXPORT DATA (HS CODE 9018) 54
5.8 KEY CONFERENCES & EVENTS, 2025?2027 55
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 56
5.10 INVESTMENT & FUNDING SCENARIO 57
5.11 CASE STUDY ANALYSIS 57
5.11.1 CASE STUDY 1: ICU BRONCHOSCOPY PERFORMANCE AND ADOPTION 57
5.11.2 CASE STUDY 2: ERCP INFECTION?CONTROL CONVERSION PATHWAY 58
5.11.3 CASE STUDY 3: OPTIMIZING TRANSBRONCHIAL CRYOBIOPSY IN INTERSTITIAL LUNG DISEASE USING AMBU ASCOPE 5 BRONCHO HD 58
5.12 IMPACT OF 2025 US TARIFFS ON DISPOSABLE ENDOSCOPES MARKET 59
5.12.1 INTRODUCTION 59
5.12.2 KEY TARIFF RATES 60
5.12.3 PRICE IMPACT ANALYSIS 60
5.12.4 IMPACT ON COUNTRIES/REGIONS 61
5.12.4.1 North America 61
5.12.4.2 Europe 61
5.12.4.3 Asia Pacific 61
5.12.5 END-USE INDUSTRY IMPACT 61
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 62
6.1 KEY EMERGING TECHNOLOGIES 62
6.1.1 CMOS & CCD IMAGING SENSORS 62
6.1.2 FIBER-OPTIC ILLUMINATION SYSTEMS 62
6.2 COMPLEMENTARY TECHNOLOGIES 62
6.2.1 AI-ASSISTED IMAGE PROCESSING AND VISUALIZATION 63
6.3 TECHNOLOGY/PRODUCT ROADMAP 63
6.3.1 SHORT TERM (2025?2027) | FOUNDATION & EARLY COMMERCIALIZATION 63
6.3.2 MID TERM (2027?2030) | EXPANSION & STANDARDIZATION 63
6.3.3 LONG TERM (2030?2035+) | MASS COMMERCIALIZATION & DISRUPTION 64
6.4 PATENT ANALYSIS 64
6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 65
6.5 FUTURE APPLICATIONS 67
6.5.1 AI-ENABLED VISUALIZATION AND DIAGNOSTIC SUPPORT 67
6.5.2 BIODEGRADABLE & ECO-FRIENDLY ENDOSCOPES 67
6.5.3 SMART ENDOSCOPES WITH EMBEDDED SENSORS 68
6.6 IMPACT OF AI/GEN AI ON DISPOSABLE ENDOSCOPES MARKET 68
6.6.1 TOP USE CASES & MARKET POTENTIAL 68
6.7 BEST PRACTICES IN DISPOSABLE ENDOSCOPES PROCESSING 69
6.7.1 CASE STUDIES OF AI IMPLEMENTATION IN DISPOSABLE ENDOSCOPES MARKET 69
6.7.2 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS 69
6.7.3 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN DISPOSABLE ENDOSCOPES MARKET 70
7 SUSTAINABILITY & REGULATORY LANDSCAPE 71
7.1 REGIONAL REGULATIONS & COMPLIANCE 71
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
7.1.2 INDUSTRY STANDARDS 73
7.2 SUSTAINABILITY INITIATIVES 74
7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF DISPOSABLE ENDOSCOPES 74
7.2.1.1 Carbon impact reduction 74
7.2.1.2 Eco-applications 74
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 74
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 75
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 76
8.1 DECISION-MAKING PROCESS 76
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 76
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
8.2.2 KEY BUYING CRITERIA 77
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 78
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 78
8.5 MARKET PROFITABILITY 78
8.5.1 REVENUE POTENTIAL 79
8.5.2 COST DYNAMICS 79
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 79
9 DISPOSABLE ENDOSCOPES MARKET, BY TYPE 80
9.1 INTRODUCTION 81
9.2 UROLOGY ENDOSCOPES 81
9.2.1 UROLOGY ENDOSCOPES SEGMENT TO HOLD MAJOR SHARE OF MARKET 81
9.3 BRONCHOSCOPES 82
9.3.1 RISING PREVALENCE OF LUNG CANCER TO BOOST SEGMENTAL GROWTH 82
9.4 CYSTOSCOPES 84
9.4.1 GROWING BURDEN OF BLADDER CANCER TO AID SEGMENTAL GROWTH 84
9.5 GI ENDOSCOPES 85
9.5.1 STRINGENT REGULATORY RECOMMENDATIONS FROM US FDA TO ACCELERATE SHIFT TOWARD SINGLE-USE GI ENDOSCOPES 85
9.6 LARYNGOSCOPES 86
9.6.1 RISING INFECTION CONTROL AND INCREASING LARYNGEAL DISORDER BURDEN TO DRIVE SEGMENTAL GROWTH 86
9.7 ARTHROSCOPES 87
9.7.1 RISING GERIATRIC POPULATION AND GROWING INCIDENCE OF ORTHOPEDIC DISEASES TO BOOST MARKET GROWTH 87
9.8 OTHER DISPOSABLE ENDOSCOPES 88
10 DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE 90
10.1 INTRODUCTION 91
10.2 SURGICAL USAGE 91
10.2.1 RISING ADOPTION OF MINIMALLY INVASIVE SURGERIES TO DRIVE SEGMENTAL GROWTH 91
10.3 DIAGNOSTIC USAGE 92
10.3.1 RISING PREFERENCE FOR SAFE AND EFFICIENT DIAGNOSTIC PROCEDURES TO DRIVE ADOPTION OF DISPOSABLE ENDOSCOPES 92
?
11 DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION 94
11.1 INTRODUCTION 95
11.2 UROLOGY 95
11.2.1 RISING PREVALENCE OF URINARY TRACT DISEASES AND CANCERS TO AID MARKET GROWTH 95
11.3 BRONCHOSCOPY 96
11.3.1 RISING INFECTION CONTROL NEEDS TO DRIVE GROWTH OF BRONCHOSCOPY SEGMENT 96
11.4 GASTROENTEROLOGY 97
11.4.1 TECHNOLOGICAL ADVANCEMENTS AND GROWING PROCEDURAL VOLUMES IN HOSPITAL ENDOSCOPY UNITS TO FUEL DEMAND 97
11.5 ENT 99
11.5.1 ABILITY OF DISPOSABLE ENT ENDOSCOPES TO REDUCE CROSS-CONTAMINATION RISKS TO DRIVE DEMAND 99
11.6 OTHER APPLICATIONS 100
12 DISPOSABLE ENDOSCOPES MARKET, BY END USER 101
12.1 INTRODUCTION 102
12.2 HOSPITALS 102
12.2.1 HOSPITALS TO DOMINATE DISPOSABLE ENDOSCOPES MARKET DURING FORECAST PERIOD 102
12.3 AMBULATORY SURGERY CENTERS 103
12.3.1 GROWING PREFERENCE FOR OUTPATIENT SURGERIES AND TECHNOLOGICAL ADVANCEMENTS TO ACCELERATE GROWTH 103
12.4 CLINICS 104
12.4.1 RISING ADOPTION OF OUTPATIENT DIAGNOSTICS AND MINOR PROCEDURES TO DRIVE SEGMENTAL GROWTH 104
12.5 OTHER END USERS 105
13 DISPOSABLE ENDOSCOPES MARKET, BY REGION 107
13.1 INTRODUCTION 108
13.2 NORTH AMERICA 109
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 110
13.2.2 US 113
13.2.2.1 US to dominate North American disposable endoscopes market during forecast period 113
13.2.3 CANADA 115
13.2.3.1 Stringent infection control standards and rising chronic disease burden to adoption of disposable endoscopes 115
13.3 EUROPE 117
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 117
13.3.2 GERMANY 120
13.3.2.1 Germany to dominate European disposable endoscopes market 120
?
13.3.3 UK 122
13.3.3.1 Growing aging population and infection control focus to boost market 122
13.3.4 FRANCE 123
13.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth 123
13.3.5 ITALY 125
13.3.5.1 Increasing aging population and prevalence of chronic diseases to boost adoption of disposable endoscopes 125
13.3.6 SPAIN 127
13.3.6.1 Rising aging population to drive market growth 127
13.3.7 REST OF EUROPE 128
13.4 ASIA PACIFIC 130
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 130
13.4.2 CHINA 133
13.4.2.1 China to account for largest share of APAC region in disposable endoscopes market 133
13.4.3 JAPAN 135
13.4.3.1 Increasing chronic diseases and geriatric population to drive Japan’s growth in market 135
13.4.4 INDIA 137
13.4.4.1 Rising disease burden and aging population to position India as key growth hub in Asia Pacific 137
13.4.5 AUSTRALIA 138
13.4.5.1 Rising cancer burden and expanding screening programs to support disposable endoscopes adoption in Australia 138
13.4.6 SOUTH KOREA 140
13.4.6.1 Robust cancer screening programs to drive strong adoption of disposable endoscopes 140
13.4.7 REST OF ASIA PACIFIC 142
13.5 LATIN AMERICA 143
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 143
13.5.2 BRAZIL 146
13.5.2.1 Brazil to account for largest share of LATAM market in 2024 146
13.5.3 MEXICO 148
13.5.3.1 Expanding healthcare infrastructure to strengthen Mexico’s position in global market 148
13.5.4 REST OF LATIN AMERICA 149
13.6 MIDDLE EAST & AFRICA 151
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 151
13.6.2 GCC COUNTRIES 153
13.6.2.1 Increasing healthcare investments and hospital expansions to drive market growth 153
13.6.3 REST OF MIDDLE EAST & AFRICA 155
?
14 COMPETITIVE LANDSCAPE 158
14.1 INTRODUCTION 158
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 158
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DISPOSABLE ENDOSCOPES MARKET 158
14.3 REVENUE ANALYSIS, 2020?2024 159
14.4 MARKET SHARE ANALYSIS, 2024 160
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 162
14.5.1 STARS 162
14.5.2 EMERGING LEADERS 163
14.5.3 PERVASIVE PLAYERS 163
14.5.4 PARTICIPANTS 163
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 165
14.5.5.1 Company footprint 165
14.5.5.2 Region footprint 165
14.5.5.3 Type footprint 166
14.5.5.4 Application footprint 167
14.5.5.5 End-user footprint 167
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 168
14.6.1 PROGRESSIVE COMPANIES 168
14.6.2 RESPONSIVE COMPANIES 168
14.6.3 DYNAMIC COMPANIES 168
14.6.4 STARTING BLOCKS 168
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 169
14.6.5.1 Detailed list of key startups/SMEs 169
14.6.5.2 Competitive benchmarking of key startups/SMEs 171
14.7 COMPANY VALUATION & FINANCIAL METRICS 172
14.7.1 FINANCIAL METRICS 172
14.7.2 COMPANY VALUATION 172
14.8 BRAND/PRODUCT COMPARISON 173
14.9 COMPETITIVE SCENARIO 173
14.9.1 PRODUCT LAUNCHES & APPROVALS 173
14.9.2 DEALS 176
14.9.3 EXPANSIONS 178
15 COMPANY PROFILES 179
15.1 KEY PLAYERS 179
15.1.1 AMBU A/S 179
15.1.1.1 Business overview 179
15.1.1.2 Products offered 180
15.1.1.3 Recent developments 181
15.1.1.3.1 Product launches & approvals 181
15.1.1.3.2 Expansions 183
15.1.1.4 MnM view 184
15.1.1.4.1 Right to win 184
15.1.1.4.2 Strategic choices 184
15.1.1.4.3 Weaknesses & competitive threats 184
15.1.2 BOSTON SCIENTIFIC CORPORATION 185
15.1.2.1 Business overview 185
15.1.2.2 Products offered 186
15.1.2.3 Recent developments 187
15.1.2.3.1 Product approvals 187
15.1.2.3.2 Deals 187
15.1.2.4 MnM view 187
15.1.2.4.1 Right to win 187
15.1.2.4.2 Strategic choices 188
15.1.2.4.3 Weaknesses & competitive threats 188
15.1.3 OLYMPUS CORPORATION 189
15.1.3.1 Business overview 189
15.1.3.2 Products offered 190
15.1.3.3 Recent developments 190
15.1.3.3.1 Product approvals 190
15.1.3.3.2 Deals 191
15.1.3.4 MnM view 191
15.1.3.4.1 Right to win 191
15.1.3.4.2 Strategic choices 191
15.1.3.4.3 Weaknesses & competitive threats 191
15.1.4 HOYA CORPORATION 192
15.1.4.1 Business overview 192
15.1.4.2 Products offered 193
15.1.4.3 Recent developments 194
15.1.4.3.1 Deals 194
15.1.4.4 MnM view 194
15.1.4.4.1 Right to win 194
15.1.4.4.2 Strategic choices 194
15.1.4.4.3 Weaknesses & competitive threats 194
15.1.5 VERATHON INC. 195
15.1.5.1 Business overview 195
15.1.5.2 Products offered 195
15.1.5.3 Recent developments 196
15.1.5.3.1 Product launches 196
15.1.5.4 MnM view 196
15.1.5.4.1 Right to win 196
15.1.5.4.2 Strategic choices 197
15.1.5.4.3 Weaknesses & competitive threats 197
15.1.6 KARL STORZ SE & CO. KG 198
15.1.6.1 Business overview 198
15.1.6.2 Products offered 198
15.1.6.3 Recent developments 199
15.1.6.3.1 Product launches 199
15.1.6.3.2 Deals 199
15.1.7 HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD. 200
15.1.7.1 Business overview 200
15.1.7.2 Products offered 200
15.1.7.3 Recent developments 202
15.1.7.3.1 Deals 202
15.1.8 INNOVEX MEDICAL CO., LTD. 203
15.1.8.1 Business overview 203
15.1.8.2 Products offered 203
15.1.9 SCIVITA MEDICAL 205
15.1.9.1 Business overview 205
15.1.9.2 Products offered 205
15.1.10 GUANGZHOU RED PINE MEDICAL INSTRUMENT CO., LTD. 206
15.1.10.1 Business overview 206
15.1.10.2 Products offered 206
15.2 OTHER PLAYERS 207
15.2.1 THE COOPER COMPANIES, INC. 207
15.2.2 ZHUHAI PUSEN MEDICAL TECHNOLOGY CO., LTD. 208
15.2.3 UROVIU CORPORATION 209
15.2.4 OTU MEDICAL 210
15.2.5 GI VIEW LTD. 211
15.2.6 TSC LIFE 212
15.2.7 RICHARD WOLF GMBH 213
15.2.8 DAICHUAN MEDICA 214
15.2.9 NEOSCOPE INC. 215
15.2.10 INTEGRATED ENDOSCOPY 216
15.2.11 HUGER MEDICAL INSTRUMENT CO., LTD. 216
15.2.12 XENOCOR 217
15.2.13 MACROLUX MEDICAL TECHNOLOGY CO., LTD. 218
15.2.14 SHENZHEN HUGEMED MEDICAL TECHNICAL DEVELOPMENT CO., LTD. 219
15.2.15 ZHEJIANG GEYI MEDICAL DEVICES CO., LTD. 220
?
16 RESEARCH METHODOLOGY 221
16.1 RESEARCH DATA 221
16.1.1 SECONDARY DATA 221
16.1.1.1 Key data from secondary sources 223
16.1.2 PRIMARY DATA 223
16.1.2.1 Key data from primary sources 225
16.1.2.2 Key industry insights 226
16.2 MARKET SIZE ESTIMATION 227
16.3 MARKET BREAKDOWN & DATA TRIANGULATION 232
16.4 MARKET RANKING ANALYSIS 232
16.5 STUDY ASSUMPTIONS 233
16.6 RESEARCH LIMITATIONS 233
16.6.1 METHODOLOGY-RELATED LIMITATIONS 233
16.6.2 SCOPE-RELATED LIMITATIONS 233
16.7 RISK ASSESSMENT 234
17 APPENDIX 235
17.1 DISCUSSION GUIDE 235
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 241
17.3 CUSTOMIZATION OPTIONS 243
17.4 RELATED REPORTS 243
17.5 AUTHOR DETAILS 244

ページTOPに戻る

List of Tables/Graphs

＜P＞TABLE 1 DISPOSABLE ENDOSCOPES MARKET: INCLUSIONS & EXCLUSIONS 26
TABLE 2 STANDARD CURRENCY CONVERSION RATES 28
TABLE 3 DISPOSABLE ENDOSCOPES MARKET: PORTER’S FIVE FORCES ANALYSIS 43
TABLE 4 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021?2030 46
TABLE 5 AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY KEY PLAYER, 2022?2024 (USD) 51
TABLE 6 AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY TYPE,
2022?2024 (USD) 52
TABLE 7 AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY REGION, 2022?2024 (USD) 53
TABLE 8 IMPORT DATA FOR DISPOSABLE ENDOSCOPE PRODUCTS UNDER HS CODE 9018, BY COUNTRY, 2019?2024 (USD THOUSAND) 54
TABLE 9 EXPORT DATA FOR DISPOSABLE ENDOSCOPE PRODUCTS UNDER HS CODE 9018, BY COUNTRY, 2019?2024 (USD THOUSAND) 54
TABLE 10 DISPOSABLE ENDOSCOPES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS (2025?2027) 55
TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 60
TABLE 12 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ORTHODONTIC SUPPLIES 60
TABLE 13 DISPOSABLE ENDOSCOPES MARKET: LIST OF PATENTS, 2022?2025 66
TABLE 14 TOP USE CASES & MARKET POTENTIAL 68
TABLE 15 DISPOSABLE ENDOSCOPES MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 69
TABLE 16 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS 69
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 21 MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 22 GLOBAL STANDARDS IN DISPOSABLE ENDOSCOPES MARKET 73
TABLE 23 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN DISPOSABLE ENDOSCOPES MARKET 75
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DISPOSABLE ENDOSCOPES 77
TABLE 25 KEY BUYING CRITERIA FOR TOP THREE DISPOSABLE ENDOSCOPE TYPES 77
TABLE 26 DISPOSABLE ENDOSCOPES MARKET: UNMET NEEDS/END-USER EXPECTATIONS 78
TABLE 27 DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023?2030 (USD MILLION) 81
TABLE 28 UROLOGY ENDOSCOPES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 82
TABLE 29 BRONCHOSCOPES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 83
TABLE 30 CYSTOSCOPES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 84
TABLE 31 GI ENDOSCOPES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 86
TABLE 32 LARYNGOSCOPES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 87
TABLE 33 ARTHROSCOPES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 88
TABLE 34 OTHER DISPOSABLE ENDOSCOPES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 89
TABLE 35 DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 91
TABLE 36 DISPOSABLE ENDOSCOPES MARKET FOR SURGICAL USAGE, BY COUNTRY,
2023?2030 (USD MILLION) 92
TABLE 37 DISPOSABLE ENDOSCOPES MARKET FOR DIAGNOSTIC USAGE, BY COUNTRY, 2023?2030 (USD MILLION) 93
TABLE 38 DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 95
TABLE 39 DISPOSABLE ENDOSCOPES MARKET FOR UROLOGY APPLICATIONS, BY COUNTRY, 2023?2030 (USD MILLION) 96
TABLE 40 DISPOSABLE ENDOSCOPES MARKET FOR BRONCHOSCOPY APPLICATIONS,
BY COUNTRY, 2023?2030 (USD MILLION) 97
TABLE 41 DISPOSABLE ENDOSCOPES MARKET FOR GASTROENTEROLOGY APPLICATIONS, BY COUNTRY, 2023?2030 (USD MILLION) 98
TABLE 42 DISPOSABLE ENDOSCOPES MARKET FOR ENT APPLICATIONS, BY COUNTRY, 2023?2030 (USD MILLION) 99
TABLE 43 DISPOSABLE ENDOSCOPES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023?2030 (USD MILLION) 100
TABLE 44 DISPOSABLE ENDOSCOPES MARKET, BY END USER, 2023?2030 (USD MILLION) 102
TABLE 45 DISPOSABLE ENDOSCOPES MARKET FOR HOSPITALS, BY COUNTRY,
2023?2030 (USD MILLION) 103
TABLE 46 DISPOSABLE ENDOSCOPES MARKET FOR AMBULATORY SURGERY CENTERS,
BY COUNTRY, 2023?2030 (USD MILLION) 104
TABLE 47 DISPOSABLE ENDOSCOPES MARKET FOR CLINICS, BY COUNTRY,
2023?2030 (USD MILLION) 105
TABLE 48 DISPOSABLE ENDOSCOPES MARKET FOR OTHER END USERS, BY COUNTRY, 2023?2030 (USD MILLION) 106
TABLE 49 DISPOSABLE ENDOSCOPES MARKET, BY REGION, 2023?2030 (USD MILLION) 109
TABLE 50 DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023?2030 (THOUSAND UNITS) 109
TABLE 51 NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 111
TABLE 52 NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 111
TABLE 53 NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (THOUSAND UNITS) 112
TABLE 54 NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023?2030 (USD MILLION) 112
TABLE 55 NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 112
TABLE 56 NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 113
TABLE 57 US: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023?2030 (USD MILLION) 114
TABLE 58 US: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 114
TABLE 59 US: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 114
TABLE 60 US: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 115
TABLE 61 CANADA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 115
TABLE 62 CANADA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 116
TABLE 63 CANADA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 116
TABLE 64 CANADA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 116
TABLE 65 EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 118
TABLE 66 EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 118
TABLE 67 EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (THOUSAND UNITS) 119
TABLE 68 EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 119
TABLE 69 EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 119
TABLE 70 EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 120
TABLE 71 GERMANY: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 120
TABLE 72 GERMANY: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 121
TABLE 73 GERMANY: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 121
TABLE 74 GERMANY: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 121
TABLE 75 UK: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023?2030 (USD MILLION) 122
TABLE 76 UK: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 122
TABLE 77 UK: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 123
TABLE 78 UK: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 123
TABLE 79 FRANCE: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 124
TABLE 80 FRANCE: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 124
TABLE 81 FRANCE: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 124
TABLE 82 FRANCE: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 125
TABLE 83 ITALY: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023?2030 (USD MILLION) 125
TABLE 84 ITALY: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 126
TABLE 85 ITALY: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 126
TABLE 86 ITALY: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 126
TABLE 87 SPAIN: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023?2030 (USD MILLION) 127
TABLE 88 SPAIN: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 127
TABLE 89 SPAIN: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 128
TABLE 90 SPAIN: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 128
TABLE 91 REST OF EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 129
TABLE 92 REST OF EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023?2030 (USD MILLION) 129
TABLE 93 REST OF EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 129
TABLE 94 REST OF EUROPE: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 130
TABLE 95 ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 131
TABLE 96 ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 131
TABLE 97 ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (THOUSAND UNITS) 132
TABLE 98 ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 132
TABLE 99 ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 132
TABLE 100 ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 133
TABLE 101 CHINA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023?2030 (USD MILLION) 134
TABLE 102 CHINA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 134
TABLE 103 CHINA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 134
TABLE 104 CHINA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 135
TABLE 105 JAPAN: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023?2030 (USD MILLION) 135
TABLE 106 JAPAN: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 136
TABLE 107 JAPAN: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 136
TABLE 108 JAPAN: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 136
TABLE 109 INDIA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023?2030 (USD MILLION) 137
TABLE 110 INDIA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 137
TABLE 111 INDIA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 138
TABLE 112 INDIA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 138
TABLE 113 AUSTRALIA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 139
TABLE 114 AUSTRALIA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 139
TABLE 115 AUSTRALIA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 139
TABLE 116 AUSTRALIA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 140
TABLE 117 SOUTH KOREA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 140
TABLE 118 SOUTH KOREA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 141
TABLE 119 SOUTH KOREA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 141
TABLE 120 SOUTH KOREA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 141
TABLE 121 REST OF ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 142
TABLE 122 REST OF ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023?2030 (USD MILLION) 142
TABLE 123 REST OF ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 143
TABLE 124 REST OF ASIA PACIFIC: DISPOSABLE ENDOSCOPES MARKET, BY END USER, 2023?2030 (USD MILLION) 143
TABLE 125 LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 144
TABLE 126 LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 144
TABLE 127 LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (THOUSAND UNITS) 145
TABLE 128 LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 145
TABLE 129 LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 145
TABLE 130 LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 146
TABLE 131 BRAZIL: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 146
TABLE 132 BRAZIL: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 147
TABLE 133 BRAZIL: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 147
TABLE 134 BRAZIL: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 147
TABLE 135 MEXICO: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 148
TABLE 136 MEXICO: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE,
2023?2030 (USD MILLION) 148
TABLE 137 MEXICO: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 149
TABLE 138 MEXICO: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 149
TABLE 139 REST OF LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 150
TABLE 140 REST OF LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023?2030 (USD MILLION) 150
TABLE 141 REST OF LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 150
TABLE 142 REST OF LATIN AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY END USER, 2023?2030 (USD MILLION) 151
TABLE 143 MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY REGION,
2023?2030 (USD MILLION) 151
TABLE 144 MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 152
TABLE 145 MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (THOUSAND UNITS) 152
TABLE 146 MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023?2030 (USD MILLION) 152
TABLE 147 MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 153
TABLE 148 MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY END USER, 2023?2030 (USD MILLION) 153
TABLE 149 GCC COUNTRIES: DISPOSABLE ENDOSCOPES MARKET, BY TYPE,
2023?2030 (USD MILLION) 154
TABLE 150 GCC COUNTRIES: DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023?2030 (USD MILLION) 154
TABLE 151 GCC COUNTRIES: DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 155
TABLE 152 GCC COUNTRIES: DISPOSABLE ENDOSCOPES MARKET, BY END USER,
2023?2030 (USD MILLION) 155
TABLE 153 REST OF MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2023?2030 (USD MILLION) 156
TABLE 154 REST OF MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET,
BY CLINICAL USAGE, 2023?2030 (USD MILLION) 156
TABLE 155 REST OF MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET,
BY APPLICATION, 2023?2030 (USD MILLION) 156
TABLE 156 REST OF MIDDLE EAST & AFRICA: DISPOSABLE ENDOSCOPES MARKET,
BY END USER, 2023?2030 (USD MILLION) 157
TABLE 157 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN DISPOSABLE ENDOSCOPES MARKET 158
TABLE 158 DISPOSABLE ENDOSCOPES MARKET: DEGREE OF COMPETITION 161
TABLE 159 DISPOSABLE ENDOSCOPES MARKET: REGION FOOTPRINT 165
TABLE 160 DISPOSABLE ENDOSCOPES MARKET: TYPE FOOTPRINT 166
TABLE 161 DISPOSABLE ENDOSCOPES MARKET: APPLICATION FOOTPRINT 167
TABLE 162 DISPOSABLE ENDOSCOPES MARKET: END-USER FOOTPRINT 167
TABLE 163 DISPOSABLE ENDOSCOPES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 169
TABLE 164 DISPOSABLE ENDOSCOPES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 171
TABLE 165 DISPOSABLE ENDOSCOPES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022?OCTOBER 2025 173
TABLE 166 DISPOSABLE ENDOSCOPES MARKET: DEALS, JANUARY 2022?OCTOBER 2025 176
TABLE 167 DISPOSABLE ENDOSCOPES MARKET: EXPANSIONS,
JANUARY 2022?OCTOBER 2025 178
TABLE 168 AMBU A/S: COMPANY OVERVIEW 179
TABLE 169 AMBU A/S: PRODUCTS OFFERED 180
TABLE 170 AMBU A/S: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022?SEPTEMBER 2025 181
TABLE 171 AMBU A/S: EXPANSIONS, JANUARY 2022?JULY 2025 183
TABLE 172 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 185
TABLE 173 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 186
TABLE 174 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS,
JANUARY 2022?SEPTEMBER 2025 187
TABLE 175 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022?JULY 2025 187
TABLE 176 OLYMPUS CORPORATION: COMPANY OVERVIEW 189
TABLE 177 OLYMPUS CORPORATION: PRODUCTS OFFERED 190
TABLE 178 OLYMPUS CORPORATION: PRODUCT APPROVALS,
JANUARY 2022?SEPTEMBER 2025 190
TABLE 179 OLYMPUS CORPORATION: DEALS, JANUARY 2022?SEPTEMBER 2025 191
TABLE 180 HOYA CORPORATION: COMPANY OVERVIEW 192
TABLE 181 HOYA CORPORATION: PRODUCTS OFFERED 193
TABLE 182 HOYA CORPORATION: DEALS, JANUARY 2022?SEPTEMBER 2025 194
TABLE 183 VERATHON INC.: COMPANY OVERVIEW 195
TABLE 184 VERATHON INC.: PRODUCTS OFFERED 195
TABLE 185 VERATHON INC.: PRODUCT LAUNCHES, JANUARY 2022?SEPTEMBER 2025 196
TABLE 186 KARL STORZ SE & CO. KG: COMPANY OVERVIEW 198
TABLE 187 KARL STORZ SE & CO. KG: PRODUCTS OFFERED 198
TABLE 188 KARL STORZ SE & CO. KG: PRODUCT LAUNCHES,
JANUARY 2022?SEPTEMBER 2025 199
TABLE 189 KARL STORZ SE & CO. KG: DEALS, JANUARY 2022?SEPTEMBER 2025 199
TABLE 190 HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW 200
TABLE 191 HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD.: PRODUCTS OFFERED 200
TABLE 192 HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD.: DEALS,
JANUARY 2022? SEPTEMBER 2025 202
TABLE 193 INNOVEX MEDICAL CO., LTD.: COMPANY OVERVIEW 203
TABLE 194 INNOVEX MEDICAL CO., LTD.: PRODUCTS OFFERED 203
TABLE 195 SCIVITA MEDICAL: COMPANY OVERVIEW 205
TABLE 196 SCIVITA MEDICAL: PRODUCTS OFFERED 205
TABLE 197 GUANGZHOU RED PINE MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW 206
TABLE 198 GUANGZHOU RED PINE MEDICAL INSTRUMENT CO., LTD.: PRODUCTS OFFERED 206
TABLE 199 THE COOPER COMPANIES, INC.: COMPANY OVERVIEW 207
TABLE 200 ZHUHAI PUSEN MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 208
TABLE 201 UROVIU CORPORATION: COMPANY OVERVIEW 209
TABLE 202 OTU MEDICAL: COMPANY OVERVIEW 210
TABLE 203 GI VIEW LTD.: COMPANY OVERVIEW 211
TABLE 204 TSC LIFE: COMPANY OVERVIEW 212
TABLE 205 RICHARD WOLF GMBH: COMPANY OVERVIEW 213
TABLE 206 DAICHUAN MEDICA: COMPANY OVERVIEW 214
TABLE 207 NEOSCOPE INC.: COMPANY OVERVIEW 215
TABLE 208 INTEGRATED ENDOSCOPY: COMPANY OVERVIEW 216
TABLE 209 HUGER MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW 216
TABLE 210 XENOCOR: COMPANY OVERVIEW 217
TABLE 211 MACROLUX MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 218
TABLE 212 SHENZHEN HUGEMED MEDICAL TECHNICAL DEVELOPMENT CO., LTD.:
COMPANY OVERVIEW 219
TABLE 213 ZHEJIANG GEYI MEDICAL DEVICES CO., LTD.: COMPANY OVERVIEW 220
TABLE 214 DISPOSABLE ENDOSCOPES MARKET: STUDY ASSUMPTIONS 233
TABLE 215 DISPOSABLE ENDOSCOPES MARKET: RISK ASSESSMENT ANALYSIS 234FIGURE 1 DISPOSABLE ENDOSCOPES MARKET SEGMENTATION & REGIONAL SCOPE 26
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS 29
FIGURE 3 DISPOSABLE ENDOSCOPES MARKET, BY TYPE, 2025?2030 (USD MILLION) 29
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN DISPOSABLE ENDOSCOPES MARKET 30
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF DISPOSABLE ENDOSCOPES MARKET 31
FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN DISPOSABLE ENDOSCOPES MARKET, 2024 32
FIGURE 7 NORTH AMERICA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 33
FIGURE 8 RISING REQUIREMENT FOR ENDOSCOPY TO DIAGNOSE AND TREAT TARGET DISEASES TO DRIVE MARKET GROWTH 34
FIGURE 9 HOSPITALS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN DISPOSABLE ENDOSCOPES MARKET IN 2024 35
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 36
FIGURE 11 NORTH AMERICA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 36
FIGURE 12 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 37
FIGURE 13 DISPOSABLE ENDOSCOPES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 14 DISPOSABLE ENDOSCOPES MARKET: PORTER’S FIVE FORCES ANALYSIS 44
FIGURE 15 DISPOSABLE ENDOSCOPES MARKET: SUPPLY CHAIN ANALYSIS 48
FIGURE 16 DISPOSABLE ENDOSCOPES MARKET: VALUE CHAIN ANALYSIS 50
FIGURE 17 DISPOSABLE ENDOSCOPES MARKET: ECOSYSTEM ANALYSIS 51
FIGURE 18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 56
FIGURE 19 DISPOSABLE ENDOSCOPES MARKET: INVESTMENT & FUNDING SCENARIO 57
FIGURE 20 NUMBER OF PATENTS PUBLISHED (JANUARY 2015─OCTOBER 2025) 65
FIGURE 21 TOP APPLICANT COUNTRIES/REGIONS FOR DISPOSABLE ENDOSCOPES
(JANUARY 2015?OCTOBER 2025) 66
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DISPOSABLE ENDOSCOPES 76
FIGURE 23 KEY BUYING CRITERIA FOR TOP THREE DISPOSABLE ENDOSCOPES 77
FIGURE 24 DISPOSABLE ENDOSCOPES MARKET: GEOGRAPHIC SNAPSHOT 108
FIGURE 25 NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET SNAPSHOT 110
FIGURE 26 EUROPE: DISPOSABLE ENDOSCOPES MARKET SNAPSHOT 117
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN DISPOSABLE ENDOSCOPES MARKET (2020?2024) 160
FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DISPOSABLE ENDOSCOPES MARKET (2024) 161
FIGURE 29 DISPOSABLE ENDOSCOPES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 164
FIGURE 30 DISPOSABLE ENDOSCOPES MARKET: COMPANY FOOTPRINT 165
FIGURE 31 DISPOSABLE ENDOSCOPES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 169
FIGURE 32 EV/EBITDA OF KEY VENDORS 172
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 172
FIGURE 34 DISPOSABLE ENDOSCOPES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 173
FIGURE 35 AMBU A/S: COMPANY SNAPSHOT (2024) 180
FIGURE 36 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 186
FIGURE 37 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024) 190
FIGURE 38 HOYA CORPORATION: COMPANY SNAPSHOT (2024) 193
FIGURE 39 RESEARCH DESIGN 221
FIGURE 40 PRIMARY SOURCES 224
FIGURE 41 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 226
FIGURE 42 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 227
FIGURE 43 TOP-DOWN APPROACH 228
FIGURE 44 BOTTOM-UP APPROACH 228
FIGURE 45 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025?2030) 230
FIGURE 46 DISPOSABLE ENDOSCOPES MARKET: CAGR PROJECTIONS 230
FIGURE 47 DATA TRIANGULATION METHODOLOGY 232